Tt3a
TT3A is an innovative Italy-based MedTech startup pioneering the development of the world’s first medical device for the endovascular treatment of ascending aortic aneurysms and dissections. Currently advancing into the pre-clinical phase, we aim to demonstrate in-vivo feasibility, efficacy, and safety, setting the stage for transformative solutions in aortic care.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
1 to 10
headcount range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Tt3a
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
- AP
Alessandro Pizzo
CEO · General Business & Management
EmailPhone - MS
Matteo Selmi
Tt3a Srl · Other
EmailPhone
Showing 2 of 2 verified contacts
Top roles at Tt3a
2 distinct titles indexed · top 2 shown.
- 1ceo
- 1tt3a srl
Sign up to unlock all 2 contacts at Tt3a
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Tt3a
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.